Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...

Decades of Alzheimer’s research has been dominated by one idea: Amyloid‑beta is the cause, and clearing it is the cure. Now, the world’s most trusted evidence authority has delivered a verdict that ...

I have been following the story here of the newest Alzheimers drugs, the first to show that they can actually slow the progression of Alzheimer's disease (AD). The benefits are modest, and come with ...

A major Cochrane review of Alzheimer’s drugs, including newly approved Kisunla, found only limited slowing of memory and ...